Expertise in
11
conditions

Karsten Nysom

Copenhagen, DK 
Expertise in
11
conditions
Copenhagen, DK 

Overview

Karsten Nysom practices practicing medicine in Copenhagen, Denmark.

Mr. Nysom is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Gliomatosis Cerebri, and Selective Mutism.

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Copenhagen, Denmark
Other Locations
Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial
A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial
Enrollment Status: Completed
Publish Date: May 12, 2026
Intervention Type: Drug
Study Drugs: Bevacizumab, Temozolomide, Irinotecan, Topotecan, Dinutuximab Beta, Cyclophosphamide
Study Phase: Phase 2
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Enrollment Status: Completed
Publish Date: October 03, 2024
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 1
A Multicenter Phase 2/3 Trial of the Efficacy and Safety of Intracerebroventricular Radioimmunotherapy Using 131I-omburtamab for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
A Multicenter Phase 2/3 Trial of the Efficacy and Safety of Intracerebroventricular Radioimmunotherapy Using 131I-omburtamab for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Enrollment Status: Terminated
Publish Date: February 13, 2024
Intervention Type: Biological
Study Drug: 131I-omburtamab
Study Phase: Phase 2/Phase 3
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Enrollment Status: Terminated
Publish Date: May 31, 2022
Intervention Type: Drug
Study Drugs: Vinblastine+Nilotinib, Vinblastine
Study Phase: Phase 2
PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
Enrollment Status: Completed
Publish Date: May 27, 2022
Intervention Type: Drug
Study Drugs: Nilotinib, Vinblastine
Study Phase: Phase 1
View 4 Less Clinical Trials

77 Total Publications

Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: January 27, 2026

Frequently Asked Questions about Karsten Nysom

Is Karsten Nysom a top-rated expert for Embryonal Tumor with Multilayered Rosettes?

MediFind is an objective health platform that identifies experts based on real-world data. Karsten Nysom is classified as an Elite expert for Embryonal Tumor with Multilayered Rosettes, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Karsten Nysom participate in research or clinical trials?

Yes. Karsten Nysom has published 77 articles and abstracts on conditions like Embryonal Tumor with Multilayered Rosettes. You can view a list of Karsten Nysom's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nysom's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile